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Introduction. Dental treatment performed in patients receiving continuous oral anticoagulant drug therapy is becoming increas-
ingly common in dental oﬃces. For these patients it is imperative to carry out careful anamnesis, as well as a multiprofessional
clinical evaluation with regard to the risk and control of hemorrhagic or thromboembolic episodes. Objectives and Material
and Methods. The aim is to evaluate postextraction hemorrhagic or thromboembolic episodes in patients who have been on
anticoagulant medications for an uninterrupted period of 48 months. Results. Among the 108 patients evaluated, 215 extractions
were performed in which there was onlyone case of postoperative bleeding. Warfarin was used by 98 patients; Warfarin associated
with salicylic acetic acid by 9 patients and salicylic acetic acid in only 1 patient. As regards the serologic tests performed,
International Normalized Ratio (INR) ranged from 0.8 to 4.9, with a mean of 3.15. Conclusion. Extractions in patients on oral
anticoagulants must be performed in the least traumatic manner possible. It is not necessary to stop anticoagulant therapy
to perform extractions. Local hemostasis techniques, such as obliterative sutures alone are suﬃcient to prevent hemorrhagic
complications.
1.Introduction
Ambulatory dental surgery in patients with hemostatic alter-
ations, and who use oral anticoagulant drugs (OAC) has
become a constant practice over the last few years, demand-
ing a speciﬁc approach by the dentist and interdisciplinary
interaction with the various health teams that follow up the
patient [1].
There is discussion on how to perform dental treatment
safely in patients on anticoagulants. Some time ago, the
American College of Cardiology (ACC) and the American
Heart Association (AHA) developed a set of practical guide-
lines that propose to develop, review, and update protocols
for cardiovascular diseases and assist with clinical proce-
dures. Some protocols suggest stopping use of the drug, in
addition to the administration of vitamin K or heparin
before procedures with potential for hemorrhage. However,
these alterations may increase the chance of an episode of
thromboembolism in patients [1, 2].
None of these schemes is risk-free, which makes it
imperative to carry out a complete evaluationofthe patient’s
systemic condition, followup of his/her degree of anticoagu-
lation, and classiﬁcation of the amplitude of surgical trauma
involved in the dental procedure to be performed. Protocols
have been researched to guarantee a treatment that prevents
t h eo c c u r r e n c eo fh e m o r r h a g e s ,a n da tt h es a m et i m e ,n o t
expose the patient to the risk of thromboembolism. Inter-
rupting anticoagulant therapy, thereby exposing the patient
to an unnecessary risk of thromboembolism, is not a
cautious attitude. Many authors have demonstrated that it2 ISRN Dentistry
is safe to perform the majority of dental surgical procedures
without risk of severe hemorrhages when the International
Normalized Index (INR) is within the therapeutic levels [3].
Patients who use OAC have their therapy monitored by
measuring the Prothrombin Time (PT). This test measures
the time for clot formation from VII factor activation to
ﬁbrincoagulumformation.Duetovariationsinthemethod-
ology, reagents, and instruments used in each laboratory, a
normalization ratio was established for PT measurements
(INR) [4]. There is increased risk of thromboembolic events
whenthe INRisbelow thetherapeuticlevel;whenit isabove,
the risk of hemorrhages increases dramatically, particularly
in the elderly [5, 6].
Based on the facts set forth, we proposed to evaluate the
quantity and severity of hemorrhagic episodes after tooth
extraction in patients on anticoagulant medications and who
have been under medical and dental treatment at the
Hemotherapy and HematologyCenter(HEMOCENTRO)of
the State University of Campinas, SP, Brazil (UNICAMP)for
an uninterrupted period of 48 months.
2.MaterialandMethods
An evaluation was made of 108 patients undergoing treat-
ment with anticoagulant drugs, who have been receiving
medical attendance at the Hemotherapy and Hematology
Center of the State University of Campinas, SP, for a con-
tinuous period of 48 months.
All the institutionalized patients, by local protocol, re-
ceive dental evaluation and treatment. In all, among the 108
patients attended by the dental service during this period,
215 extractions were performed, and all the procedures were
carried out without stopping the anticoagulant drug.
During the ﬁrst consultation, routine oral exams were
performed, such as PI (plaque index), GI (gingival index),
DMF-T (decayed, missing and ﬁlled teeth) and panoramic
radiographs [7, 8]. Before extraction, the INR was requested
and the procedure was only performed if it were within
the acceptable limit for each patient. Because the patients
who were on oral anticoagulant drugs had prosthetic valves,
prophylactic antibiotics were administered, in accordance
with the AHS (American Hearth Society); that is to say,
ad o s ee q u i v a l e n tt o2 go n eh o u rb e f o r et h es u r g i c a l
procedure[9]. The extractions were performed with regional
block anesthetic techniques and, if necessary, inﬁltrative
intraligamentary anesthesia. The surgical technique was
performed in the least traumatic manner possible. After
removal of the tooth, obliterative suturing (multiples and
several sutures in the one region) was performed and the
patient was recommended to use an ice pack on the face,
physical rest, and to eat cold food of a soft consistency. No
other local hemostatic was used, except for the suture itself.
All the patients were informed of the nonmandatory
nature of the research. It was also emphasized that noncoop-
eration with the research would not result in any changes in
their medical clinical treatment. The research was submitted
to the Research Ethics Committee of the Medical Science
Faculty of the State University of Campinas for approval,
which was granted.
Table 1:Listofbase systemicdiseases inpatients who were submit-
ted to tooth extractions.
Base disease Number of patients
Thrombosis 34
Valvulopathy 30
CVA 30
Cardiopathy 8
Cirrhosis 3
Chagas Disease 2
Pulmonary embolism 1
Total 108
Table 2:Plaqueindexofpatientswhounderwenttoothextractions.
Plaque index Number of patients
01 6
14 6
22 9
31 7
Total 108
Table 3: Gingival index of patients who underwent tooth extrac-
tions.
Gingival index Number of patients
02 3
15 5
21 6
31 4
Total 108
3.Results
Of the 108 patients, 61 were women and 47 men. The
patients’ ages ranged from 13 to 80 years (median of
48.5 years). The most frequent base systemic disease was
thrombosis, followed by valvulopathy, cerebrovascular acci-
dent (CVA), cardiopathy, Chagas disease, and pulmonary
embolism (Table 1). Warfarin was used by 98 patients;
Warfarin wasassociatedwithsalicylicaceticacidby9patients
and salicylic acetic acid in only 1 patient.
As regards the oral condition of these patients, the mean
DMF-T was 13.8. Evaluation of the plaque and gingival
i n d e x e si ss h o w ni nT a b l e s2 and 3.W i t hr e g a r dt ot h e
serological tests performed, the INR ranged from 0.8 to 4.9,
with a mean of 3.15 (Table 4). Of the 215 extractions there
was postoperative bleeding in only 1 case. This patient was a
72-year-old man, the IRN was 1.57 and the tooth 37 was the
one extracted.
4.Discussion
In patients who make continuous use of oral anticoagulant
drugs, it is imperative to carry out careful anamnesis, as
well as a multiprofessional clinical evaluation with regardISRN Dentistry 3
Table 4: Correlation between INR of patients with the number of
tooth extractions performed.
INR Number of tooth extractions
0.5–1.0 7
1.01–1.5 36
1.51–2.0 50
2.01–2.5 58
2.51–3.0 34
3.01–3.5 17
3.51–4.0 9
4.01–4.5 2
4.51–5.0 2
Total 215
to the risk and control of hemorrhagic or thromboembolic
episodes [10].
It is imperative to have the patient’s degree of anticoagu-
lation undermedical control, and it must be checkedperiod-
ically to verify whether the necessary hemostatic therapeutic
level is being maintained. For this purpose, the prothrombin
time isused, theresult ofwhich may beexpressed in seconds,
inprothrombinactivity orinINR,which must beperformed
in a maximum interval of 4 weeks, as recommended by
the American College of Chest Physicians [3]. Generally
speaking, the therapeutic interval of INR should remain
between 2.0 and 3.5, but depending on the type of disease
presented by the patient, higher INR values are considered
therapeutic [5–7].
Lippert and Gutschik published recommendations in
which the INR should not be higher than 4.0, and preferably
lower than 3.0, before the patient on an anticoagulant is
submitted to dental procedures with high risk of bleeding
[11].
The recommendations of some authors for various den-
talsurgicalproceduresindicatethatforsimpleextractions,or
when minimal bleeding is expected, an INR lower than 4.0
is acceptable. For cases of moderate bleeding, included and
impacted third molar surgeries or multiple extractions, the
INRshould be reduced;in caseswhere greater hemorrhage is
expected, an INR lower than 3.0 is indicated; and when the
INR is over 5.0, no surgeries should be performed [5, 6, 11–
13].
When evaluating the IRN results of our patients, these
values ranged from 0.8 to 4.9, with a mean of 3.15. We
observed that in the specialized literature there is no
unanimityasregardsthemaximumvaluesofIRNconsidered
safe for the patient to be submitted to tooth extractions.
Nevertheless,eveninthose patients with IRNover4.0,which
wouldbeconsideredhighbysome authors[6,11],we hadno
episodesofhemorrhages. Ontheotherhand,theonlypatient
who presented hemorrhage had an IRN of 1.57, a value
considered safe by all the researched authors [5, 6, 11–13].
Elderly patients are among those who most beneﬁt from
anticoagulant treatment; however, they are also among those
with the greatest risk of hemorrhagic complications [6, 14].
Apparently we had no explicit factor that would justify the
hemorrhagic episodein theonlycase weinvestigated. Wecan
emphasize thatthepatientwaselderly(72yearsofage)which
corroborates the literature stating that they are the patients
most susceptible to hemorrhages.
Many authors are suﬃciently concerned to point out
the necessity of using an atraumatic surgical technique and
the application of local conventional measures to control
hemostasis, inwhich theadequatesutureisextremely impor-
tant [1, 14–17].
Maintenance of the anticoagulant medication has been
recommended by an increasing number of researches, which
observed a minimal incidence of hemorrhagic episodes
after surgeries, in which the patients’ values in PT and/or
in INR were within the therapeutic indexes [10, 14, 16].
This protocol has been even further reinforced by authors
who emphasize the use of local hemostatics, aﬃrming their
eﬃciency in the prevention and control of postoperative
hemorrhages [17–19]. Our survey showed similar results
with a minimum rate of postoperative bleeding (one case)
controlled by local measures with plugging. These guide-
lines are also recommended by the British Committee for
Standards in Hematology, which states the risk of bleeding
in these patients when maintaining the INR between 2 and
4 is low for dental surgeries, and that the interruption of
anticoagulant therapy would not be justiﬁed due to the
increase in the risk of thrombosis.
Itis imperative to evaluatethe risks oftransoperative and
postoperative hemorrhage, as well as the amount of surgical
trauma to which this patient would be subjected in order
to establish an adequate attendance protocol. Therefore, we
point out that performing a surgical procedure with the
least amount of trauma possible, strict observance of all the
steps of the surgical procedure, including adequate suturing,
and the patient’s compliance with the postoperative recom-
mendations must be primordial factors to consider at all
times in all patients, and especially in those on anticoagulant
medications.
5.Conclusion
Extractions in patients on oral anticoagulants must be per-
formed in the least traumatic manner possible. It is not nec-
essary to stop anticoagulant therapy to perform extractions.
Local hemostatic techniques such as obliterative sutures
alone are suﬃcient.
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